× Key messages Background Findings Perspectives Expert commentary
Go back | list
format_size dark_mode
icon-previous icon-next

Perspectives

How does this study impact clinical practice?

  • AHCL was superior to 670G in reducing daytime hyperglycemia by -3% points, without increasing hypoglycemia.
  • Both systems were safe regarding severe hypoglycemia and diabetic ketoacidosis.
  • AHCL was superior to 670G for 24 TIR70-180.
  • HbA1c was reduced by 0.5% with AHCL and by 0.3% with 670G.
  • AHCL was superior to 670G in overall treatment satisfaction.